Functional preservation of benzodiazepine receptors of the primary somatosensory cortex in Creutzfeldt-Jakob disease: A pharmacologic-evoked potential study

Clinical Neuropharmacology

Volumn 19, Issue 1, 1996, Pages 87-91

  Aguglia, U ^a,b   Oliveri, R L ^a   Gambardella, A ^a   Talerico, G ^a   Zappia, M ^a   De Sarro, G B ^a   Quattrone, A ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Clinica Neurologica   (Italy)

Author keywords

Creutzfeldt Jakob disease; Diazepam; Flumazenil; Somatosensory evoked potentials; Aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUMAZENIL;

AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDIAN NERVE; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; VISUAL SYSTEM;

EID: 0030028364     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619010-00008     Document Type: Article

References (17)

1. Aguglia U, Gambarelli D, Farnarier G, Quattrone A. Different susceptibility of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiological-neuropathological study). Electroencephalogr Clin Neurophysiol 1991;78:413-23.
2. Aguglia U, Oliveri RL, Gambardella A, Quattrone A. Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease. A pharmacologically-evoked potential study. J Neurol 1992;240:25-7.
3. Haefely W. Antagonists of benzodiazepines: functional aspects. In: Biggio G, Costa E, eds. Benzodiazepine recognition site ligands: biochemistry and pharmacology. New York: Raven Press, 1983:73-93.
4. Allison T, McCarthy G, Wood CC, Jones SJ. Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings. Brain 1991;114:2465-2503.
5. Savic I, Widen L, Stone-Elander S. Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 1991;337:133-7.
6. Aguglia U, Farnarier G, Régis H, Oliveri RL, Quattrone A. Sensory evoked potentials in Creutzfeldt-Jakob disease. Eur Neural 1990;30:157-61.
7. D values with positron emission tomography. Eur J Pharmacol 1992;213:107-15.
8. Möler H, Richades JC. Agonist and antagonist benzodiazepine receptor interaction in vivo. Nature 1981;294:763-5.
9. Keller A, White EL. Distribution of glutamic acid decarboxylase-immunoreactive structures in the barrel region of mouse somatosensory cortex. Neurosci Lett 1986;66:245-50.
10. Chmielowska J, Stewart MG, Bourne RC. Gamma-aminobutyric acid (GABA) immunoreactivity in mouse and rat first somatosensory (SI) cortex: description and comparison. Brain Res 1988;439:155-68.
11. Ren JQ, Aika Y, Heizmann CW, Kosaka T. Quantitative analysis of neurons and glial cells in the rat somatosensory cortex, with special reference to GABAergic neurons and paralbumin-containing neurons. Exp Brain Res 1992;92:1-14.
12. Alloway KD, Burton H. Differential effects of GABA and bicuculline on rapidly- and slowly-adapting neurons in primary somatosensory cortex of primates. Exp Brain Res 1991;85:598-610.
13. Klotz U, Kanto J. Pharmacokinetics and clinical use of flumazenil (RO 15-1788). Clin Pharmacokinet 1988;14:1-12.
14. Lee LG, Blair RDG. Evolution of EEG and visual evoked response changes in Jakob Creutzfeldt disease. Electroencephalogr Clin Neurophysiol 1973;35:133-42.
15. Grapperon J, Heraut LA. Potels évoquées et maladie de Creutzfeldt-Jakob. In: Court LA, ed. Virus non conventionnels et affections du système nerveux central. Paris: Masson, 1983:208-11.
16. Calleja J, Carpizo R, Berciano J, Quintial C, Polo J. Serial waking-sleep EEGs and evolution of somatosensory potentials in Creutzfeldl-Jakob disease. Electroencephalogr Clin Neurophysiol 1985;60:504-8.
17. Shibasaki H, Yamashita Y, Kuroiwa Y. Electroencephalographic studies of myoclonus. Myoclonus-related cortical spikes and high amplitude somatosensory evoked potentials. Brain 1978;101:460-77.